ThromboGenics NV (Euronext Brussels: THR), a Belgium-based biopharmaceutical company developing novel medicines for back of the eye disease, with a... ...http://www.pressreleasepoint.com/thrombogenics-nv-presenting-new-ophthalmic-research-data-16th-euretina-congress-copenhagen
Mumbai: According to the latest Forbes list Mukesh Ambani Chairman of Reliance Industries once again became India's richest person with a net worth... ...http://www.siasat.com/news/22-7-billion-mukesh-ambani-becomes-richest-indian-1026806/
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar version of AbbVie's top-selling arthritis... ...https://in.news.yahoo.com/fda-approves-amgens-cheaper-copy-arthritis-drug-humira-205018669--finance.html
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the... ...http://www.pressreleasepoint.com/ablynx-receives-transparency-notification-gam-holding-ag-gam-international-management-limited-and-ta
EAST HANOVER, N.J. , Sept. 23, 2016 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has granted three... ...http://in.advfn.com/news_Novartis-receives-three-new-FDA-approvals-for-the_72512730.html
MP-NAT however test execution was...